Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.61 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.61 |
| ▸ | CDK9 | P50750 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | GFER | P55789 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.56 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 2/20 | 0.50 |
| ▸ | F13A1 | P00488 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid SCHEMBL11084365 | 0.98 | TP53 (0.58) | TP53TSHREPHX2EPHX1CDK9 | |
| Hydroxyamine SCHEMBL5622599 | 0.92 | EPHX2 (0.64) | TP53TSHREPHX2EPHX1CDK9 | |
| Hydrazine SCHEMBL5624205 | 0.92 | TP53 (0.64) | TP53TSHREPHX2EPHX1CDK9 | |
| SCHEMBL7634 | 0.92 | EPHX2 (0.70) | TP53TSHREPHX2EPHX1CDK9 | |
| Benzene SCHEMBL28162617 | 0.92 | EPHX2 (0.70) | TP53TSHREPHX2EPHX1CDK9 | |
| SCHEMBL11018412 | 0.91 | TP53 (0.56) | TP53TSHREPHX2EPHX1CDK9 | |
| Phenylurea SCHEMBL28265514 | 0.91 | GAA (0.73) | TP53TSHREPHX2EPHX1CDK9 | |
| Iodide SCHEMBL5706290 | 0.90 | EPHX2 (0.67) | TP53TSHREPHX2EPHX1CDK9 | |
| SCHEMBL11353365 | 0.90 | EPHX2 (0.67) | TP53TSHREPHX2EPHX1CDK9 | |
| Fluoride SCHEMBL10885265 | 0.90 | EPHX2 (0.67) | TP53TSHREPHX2EPHX1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1420013-B1 | Process for hydrogenating aromatic urethanes in the presence of a supported ruthenium catalyst | EVONIK DEGUSSA GMBH (DE) | 2008-04-02 | — | — | EP | claimed |
| EP-1420012-B1 | Process for the preparation of aliphatic isocyanates from aromatic isocyanates | DEGUSSA (DE) | 2006-11-02 | — | — | EP | claimed |
| US-6924385-B2 | Method for synthesis of aliphatic isocyanates from aromatic isocyanates | DEGUSSA AG (DE) | 2005-08-02 | — | — | US | claimed |
| US-6809215-B2 | SUCH AS CONVERSION OF DIBUTYL 4,4'-METHYLENEDICARBANILATE TO DIBUTYL 4,4'-METHYLENEDICYCLOHEXYLCARBAMATE WITH LOW TRANS-TRANS ISOMER CONTENT | DEGUSSA AG (DE) | 2004-10-26 | — | — | US | claimed |
| US-20040097752-A1 | Method for synthesis of aliphatic isocyanates from aromatic isocyanates | DEGUSSA AG (DE) | 2004-05-20 | — | — | US | claimed |
| US-20040097661-A1 | Method for hydrogenation of aromatic urethanes in the presence of a supported rutheniun catalyst | DEGUSSA AG (DE) | 2004-05-20 | — | — | US | claimed |
| CN-117106337-A | Preparation method of starch-based 3D printing ink suitable for high printability | 江南大学 | 2023-11-24 | — | — | CN | disclosed |
| CN-116768763-A | Preparation method and application of alicyclic carbamate | 中国科学院过程工程研究所 | 2023-09-19 | — | — | CN | disclosed |
| WO-2023119900-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND COLOR FILTER | 株式会社レゾナック | 2023-06-29 | — | — | WO | disclosed |
| US-6924385-B2 | Method for synthesis of aliphatic isocyanates from aromatic isocyanates | DEGUSSA AG (DE) | 2005-08-02 | — | — | US | disclosed |
| US-6809215-B2 | SUCH AS CONVERSION OF DIBUTYL 4,4'-METHYLENEDICARBANILATE TO DIBUTYL 4,4'-METHYLENEDICYCLOHEXYLCARBAMATE WITH LOW TRANS-TRANS ISOMER CONTENT | DEGUSSA AG (DE) | 2004-10-26 | — | — | US | disclosed |
| US-20040097752-A1 | Method for synthesis of aliphatic isocyanates from aromatic isocyanates | DEGUSSA AG (DE) | 2004-05-20 | — | — | US | disclosed |
| US-20040097661-A1 | Method for hydrogenation of aromatic urethanes in the presence of a supported rutheniun catalyst | DEGUSSA AG (DE) | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097752-A1 | Method for synthesis of aliphatic isocyanates from aromatic isocyanates | DBI, ALKBH3, ECI1 | TP53 3043/4885TSHR 4617/4885EPHX2 1125/4885 |
| US-20040097661-A1 | Method for hydrogenation of aromatic urethanes in the presence of a supported rutheniun catalyst | HRH4, BET1, HRH3 | TP53 3353/4885TSHR 4217/4885EPHX2 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.